证券之星消息，常山药业(300255)01月09日在投资者关系平台上答复投资者关心的问题。
投资者：您好，请问艾本那肽药学审评暂停后，董秘曾回复：因沟通交流需要，公司需补充部分资料。请问，目前资料补充情况怎么样了？什么时间可以提交？何时能恢复药学审评？
常山药业董秘：投资者，您好！公司正在积极推进上述工作。感谢您的关注！
以上内容为证券之星据公开信息整理，由智能算法生成（网信算备310104345710301240019号），不构成投资建议。
- Headlines
- 常山药业：公司正在积极推进上述工作
常山药业：公司正在积极推进上述工作
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Risk Disclaimer
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Got it
Risk Disclaimer
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Got it
Write a comment
0 0 0
LikeLoveLaughing CryRespectEmmSadAngry
Tap to Select a Mood
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
Use the share button in your browser
to share the page with your friends
Tap here to share
No comments yet. Write one.
Related Stocks Related Stocks
Latest
18:46
伯恩斯坦：将洛克希德马丁目标价从607美元下调至548美元。
LMT+1.05%
18:45
Shanghai Stock Exchange: This week, regulatory measures such as written warnings were taken against 58 cases of abnormal securities trading behaviors including market manipulation and false declarations, and special investigations were conducted on 15 significant matters of listed companies. One suspected illegal case was reported to the Securities Regulatory Commission.
18:44
According to documents from the Hong Kong Stock Exchange, Xiaomi Group repurchased 279,800 Class B shares on January 10, costing 9.4 million HKD.
HKEX-0.85%
Statement
This page is machine-translated. Futubull tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation.